Biocon plunges into profit in the third quarter
Bangalore based biotechnology major Biocon has recorded a profit of 81 crores this quarter.
Bangalore based biotechnology major Biocon has recorded a profit of 81 crores this quarter.
Indian pharmaceutical companies are reworking their strategies for Europe to cope with the intense pressure on drug prices because of changing trends in the key market.